Overview

Pharmacokinetic Study Of Ibuprofen Injection (IVIb) In Healthy Adult Subjects

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the pharmacokinetic profile of a single dose of IVIb administered over 5-7 minutes.
Phase:
Phase 1
Details
Lead Sponsor:
Cumberland Pharmaceuticals
Treatments:
Ibuprofen